MDTNYSEHealthcare

MEDTRONIC PLC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$101.80

-2.90%

Alpha Vantage · 11/6/2026

Industry: Medical DevicesCategory: Domestic Common StockCurrency: USDNews: 1 recent

Analyze MDT free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

+16.0%

3 months

+14.8%

6 months

+36.0%

1 year

+16.8%

Year to date

+8.7%

52-week range

$72.51 – $104.96

Fundamental snapshot

Latest reported period: Jul 31, 2026

Sharadar reported data

Market cap

$130.22B

P/E

24.9

P/B

2.6

P/S

3.5

Revenue

$37.54B

Net income

$5.23B

Diluted EPS

4.07

Gross margin

65.00%

Net margin

13.90%

Return on equity

10.60%

Total debt

$28.15B

Cash

$1.69B

Free cash flow

$6.13B

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Jul 31, 2026	$9.76B	$1.47B	65.00%	15.10%	$1.29B
Apr 24, 2026	$9.81B	$1.24B	65.40%	12.70%	$2.09B
Jan 23, 2026	$9.02B	$1.14B	63.80%	12.70%	$2.3B
Oct 24, 2025	$8.96B	$1.37B	65.80%	15.30%	$457M
Jul 25, 2025	$8.58B	$1.04B	65.00%	12.10%	$584M
Apr 25, 2025	$8.93B	$1.06B	64.70%	11.80%	$2.07B
Jan 24, 2025	$8.29B	$1.29B	66.50%	15.60%	$2.1B
Oct 25, 2024	$8.4B	$1.27B	64.90%	15.10%	$554M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent MDT news

All market news

Morningstar·Nov 4, 202653 signal

Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Medtronic plc have launched a new educational initiative to improve understanding of deep brain stimulation (DBS) among people with Parkinson's disease and their caregivers. This partnership aims to bridge the knowledge gap surrounding DBS, an established treatment for certain Parkinson's symptoms, by providing accessible resources such as an online hub, practical guide, and webinars. The goal is to empower patients and families to make informed decisions and have meaningful conversations with their healthcare teams about treatment options.

Original source